THE IMPACT OF MENTAL DISORDERS AND PSYCHIATRIC TREATMENT ON THE OCCURRENCE AND COURSE OF TAKOTSUBO SYNDROME - REVIEW
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.6419Keywords:
Takotsubo, Psychotherapy, Mental Health Disorders, AntidepressantsAbstract
The aim of this review was to summarize existing knowledge on pathophysiology and analyze the influence of mental health disorders and psychiatric treatment on the occurrence and course of Takotsubo syndrome (TTS). This review paper was based on resources available in the PubMed database; articles were identified using the following keywords: [takotsubo] + [SNRI; SSRI; ECT; psychotherapy; anxiolytics; neuroleptics]. Additionally, a manual search of the literature cited in the articles was conducted. In order that we could treat TTS properly, we need to know its pathophysiology. The current approach regards a combination of various pathophysiological mechanisms rather than one mechanism alone. Although firstly considered as “stress” or “catecholamine”, Takotsubo cardiomyopathy is more than a simple reaction to stress or catecholamine surge. Novel data indicate a complex interplay between endothelial dysfunction, inflammatory, hormones and neurotransmitters. That leads us to the conclusion that we should treat it interdisciplinary. As there are currently no specific treatments for Takotsubo syndrome, a niche for neurocardiology is emerging. This could lead to developing new management approaches, including broader application of cognitive behavioral therapy and cooperation between cardiologists and psychiatrists.
References
Andrade C. (2021). β-Blockers and the Risk of New-Onset Depression: Meta-analysis Reassures, but the Jury Is Still Out. The Journal of clinical psychiatry, 82(3), 21f14095. https://doi.org/10.4088/JCP.21f14095
Angelini, P., Uribe, C., & Tobis, J. M. (2021). Pathophysiology of Takotsubo Cardiomyopathy: Reopened Debate. Texas Heart Institute journal, 48(3), e207490. https://doi.org/10.14503/THIJ-20-7490
Antosik-Wójcińska, A. Z., Dominiak, M., Mierzejewski, P., Jażdżyk, P., Gazdag, G., Takacs, R., & Wichniak, A. (2021). Changes in the Practice of Electroconvulsive Therapy in Poland: A Nationwide Survey Comparing Data Between 2005 and 2020. Neuropsychiatric disease and treatment, 17, 605–612. https://doi.org/10.2147/NDT.S296210
Arcari, L., Camastra, G., Sclafani, M., Ciolina, F., Belmonte, E., Castiello, T., Danti, M., Sbarbati, S., & Cacciotti, L. (2026). SGLT2 inhibitors therapy in patients with acute Takotsubo syndrome. International journal of cardiology, 452, 134262. https://doi.org/10.1016/j.ijcard.2026.134262
Angermann, C. E., Assmus, B., Anker, S. D., Asselbergs, F. W., Brachmann, J., Brett, M. E., Brugts, J. J., Ertl, G., Ginn, G., Hilker, L., Koehler, F., Rosenkranz, S., Zhou, Q., Adamson, P. B., Böhm, M., & MEMS-HF Investigators (2020). Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF). European journal of heart failure, 22(10), 1891–1901. https://doi.org/10.1002/ejhf.1943
Asci, H., Ozmen, O., Erzurumlu, Y., Sofu, A., Icten, P., & Kaynak, M. (2022). Agomelatine protects heart and aorta against lipopolysaccharide-induced cardiovascular toxicity via inhibition of NF-kβ phosphorylation. Drug and chemical toxicology, 45(1), 133–142. https://doi.org/10.1080/01480545.2019.1663209
Brazdil, V., Kala, P., Hudec, M., Poloczek, M., Kanovsky, J., Stipal, R., Jerabek, P., Bocek, O., Pail, M., & Brazdil, M. (2022). The role of central autonomic nervous system dysfunction in Takotsubo syndrome: a systematic review. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 32(1), 9–17. https://doi.org/10.1007/s10286-021-00844-z
Brunetti, N. D., Santoro, F., De Gennaro, L., Correale, M., Gaglione, A., & Di Biase, M. (2016). Drug treatment rates with beta-blockers and ACE-inhibitors/angiotensin receptor blockers and recurrences in takotsubo cardiomyopathy: A meta-regression analysis. International journal of cardiology, 214, 340–342. https://doi.org/10.1016/j.ijcard.2016.03.196
Bymaster, F. P., Zhang, W., Carter, P. A., Shaw, J., Chernet, E., Phebus, L., Wong, D. T., & Perry, K. W. (2002). Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology, 160(4), 353–361. https://doi.org/10.1007/s00213-001-0986-x
Cardoner, N., Gutiérrez-Rojas, L., Saiz, P., Lahera, G., Álvarez-Mon, M. Á., Alonso Ortega, P., & Pérez-Páramo, M. (2025). Does pregabalin offer potential as a first-line therapy for generalized anxiety disorder? A meta-analysis of efficacy, safety, and cost-effectiveness. Frontiers in pharmacology, 16, 1483770. https://doi.org/10.3389/fphar.2025.1483770
Cattaneo, M. M., Pravatà, E., Provenzi, M., Moccetti, M., Kaelin, A., Sudano, I., Biasucci, L., Gallino, C., Limoni, C., Calanchini, C., Gallino, A., Crea, F., & Cattaneo, M. (2020). Role of the central autonomic nervous system intrinsic functional organisation and psychosocial factors in primary microvascular angina and Takotsubo syndrome. Open heart, 7(2), e001315. https://doi.org/10.1136/openhrt-2020-001315
Clifford, K., Chaudhry, W., Muscat, S., Connors, C., & Whitesell, D. (2019). Reinitiation of Electroconvulsive Therapy 4 Weeks After the Diagnosis of ECT-Induced Takotsubo Cardiomyopathy. Psychosomatics, 60(1), 93–96. https://doi.org/10.1016/j.psym.2018.05.009
Compare, A., Bigi, R., Orrego, P. S., Proietti, R., Grossi, E., & Steptoe, A. (2013). Type D personality is associated with the development of stress cardiomyopathy following emotional triggers. Annals of behavioral medicine : a publication of the Society of Behavioral Medicine, 45(3), 299–307. https://doi.org/10.1007/s12160-013-9474-x
De Roock, S., Beauloye, C., De Bauwer, I., Vancraynest, D., Gurne, O., Gerber, B., & Hantson, P. (2008). Tako-tsubo syndrome following nortriptyline overdose. Clinical toxicology (Philadelphia, Pa.), 46(5), 475–478. https://doi.org/10.1080/15563650701519786
Edinoff, A. N., Nix, C. A., Hollier, J., Sagrera, C. E., Delacroix, B. M., Abubakar, T., Cornett, E. M., Kaye, A. M., & Kaye, A. D. (2021). Benzodiazepines: Uses, Dangers, and Clinical Considerations. Neurology international, 13(4), 594–607. https://doi.org/10.3390/neurolint13040059
Elhami, N., & Engerström, L. (2021). Venlafaxin misstänks ha utlöst livshotande takotsubosyndrom [Venlafaxine was suspected to have triggered life-threatening takotsubo syndrome]. Lakartidningen, 118, 20187.
El-Sayed, A. M., Brinjikji, W., & Salka, S. (2012). Demographic and co-morbid predictors of stress (takotsubo) cardiomyopathy. The American journal of cardiology, 110(9), 1368–1372. https://doi.org/10.1016/j.amjcard.2012.06.041
Forman, M. B., Sutej, P. G., & Jackson, E. K. (2011). Hypertension, tachycardia, and reversible cardiomyopathy temporally associated with milnacipran use. Texas Heart Institute journal, 38(6), 714–718.
Gamble, D. T., Ross, J., Khan, H., Cheyne, L., Rudd, A., Srivanasan, J., Horgan, G., Hogg, D., Myint, P. K., Newby, D. E., Williams, C., Gray, S. R., & Dawson, D. (2026). Physical Exercise or Cognitive Behavioral Therapy for Takotsubo Cardiomyopathy: A Randomized Controlled Trial. Circulation. Heart failure, 19(3), e013229. https://doi.org/10.1161/CIRCHEARTFAILURE.125.013229
Gopal, A., Kamrada, C., Awad, A., Chalhoub, M., Basit, J., & Alraies, M. C. (2026). Association of Baseline SSRI use with post-STEMI outcomes in patients with depression. International journal of cardiology, 460, 134585. https://doi.org/10.1016/j.ijcard.2026.134585
Garakani, A., Murrough, J. W., Freire, R. C., Thom, R. P., Larkin, K., Buono, F. D., & Iosifescu, D. V. (2020). Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Frontiers in psychiatry, 11, 595584. https://doi.org/10.3389/fpsyt.2020.595584
Hoffmann, U., Nahrendorf, M., Shin, L. M., Fayad, Z. A., & Pitman, R. K. (2017). Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study. Lancet (London, England), 389(10071), 834–845. https://doi.org/10.1016/S0140-6736(16)31714-7
Jaguszewski, M., Osipova, J., Ghadri, J. R., Napp, L. C., Widera, C., Franke, J., Fijalkowski, M., Nowak, R., Fijalkowska, M., Volkmann, I., Katus, H. A., Wollert, K. C., Bauersachs, J., Erne, P., Lüscher, T. F., Thum, T., & Templin, C. (2014). A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction. European heart journal, 35(15), 999–1006. https://doi.org/10.1093/eurheartj/eht392
Jang, S. H., Nam, J. H., Lee, J., & Chang, M. C. (2019). Takotsubo cardiomyopathy associated with serotonin syndrome in a patient with stroke: A case report. Medicine, 98(13), e15057. https://doi.org/10.1097/MD.0000000000015057
Jann M. W. (1988). Buspirone: an update on a unique anxiolytic agent. Pharmacotherapy, 8(2), 100–116. https://doi.org/10.1002/j.1875-9114.1988.tb03543.x
Jia, P., Liu, C., Wu, N., Jia, D., & Sun, Y. (2018). Agomelatine protects against myocardial ischemia reperfusion injury by inhibiting mitochondrial permeability transition pore opening. American journal of translational research, 10(5), 1310–1323.
Kajantie, E., & Phillips, D. I. (2006). The effects of sex and hormonal status on the physiological response to acute psychosocial stress. Psychoneuroendocrinology, 31(2), 151–178. https://doi.org/10.1016/j.psyneuen.2005.07.002
Kent, L. K., Weston, C. A., Heyer, E. J., Sherman, W., & Prudic, J. (2009). Successful retrial of ECT two months after ECT-induced takotsubo cardiomyopathy. The American journal of psychiatry, 166(8), 857–862. https://doi.org/10.1176/appi.ajp.2008.08081278
Kezuka, D., Haruyama, A., Suzuki, E., & Sakuma, K. (2024). A case of reinitiation of modified electroconvulsive therapy 2 weeks after modified electroconvulsive therapy-induced Takotsubo cardiomyopathy in a male patient with major depressive disorder. PCN reports : psychiatry and clinical neurosciences, 3(2), e221. https://doi.org/10.1002/pcn5.221
Kido, K., & Guglin, M. (2017). Drug-Induced Takotsubo Cardiomyopathy. Journal of cardiovascular pharmacology and therapeutics, 22(6), 552–563. https://doi.org/10.1177/1074248417708618
Kinoshita, M., Kinoshita, M., Takahashi, R., Mutoh, S., Kakuta, N., & Tanaka, K. (2023). The Safety and Strategies for Reinitiating Electroconvulsive Therapy After ECT-Induced Takotsubo Cardiomyopathy: A Case Report and Systematic Review. The journal of ECT, 39(3), 185–192. https://doi.org/10.1097/YCT.0000000000000905
Krishnamoorthy, P., Garg, J., Sharma, A., Palaniswamy, C., Shah, N., Lanier, G., Patel, N. C., Lavie, C. J., & Ahmad, H. (2015). Gender Differences and Predictors of Mortality in Takotsubo Cardiomyopathy: Analysis from the National Inpatient Sample 2009-2010 Database. Cardiology, 132(2), 131–136. https://doi.org/10.1159/000430782
Kurisu, S., Inoue, I., Kawagoe, T., Ishihara, M., Shimatani, Y., Nakama, Y., Kagawa, E., Dai, K., & Ikenaga, H. (2010). Presentation of Tako-tsubo cardiomyopathy in men and women. Clinical cardiology, 33(1), 42–45. https://doi.org/10.1002/clc.20700
Lafferty, C. J., Lafferty, K. M., Bhat, T., Olson, P. C., Atoot, A., Daneshvar, F., & McCord, D. A. (2017). Takotsubo Cardiomyopathy Precipitated by Tapering of Anxiolytic Medication: A Case Report. Clinical Medicine Insights. Cardiology, 11, 1179546817746643. https://doi.org/10.1177/1179546817746643
Leissner, P., Sundelin, R., Rondung, E., Humphries, S., Held, C., Spaak, J., Ulvenstam, A., Nordenskjöld, A., Norlund, F., Kövamees, L., Lyngå, P., Olsson, E., & Tornvall, P. (2026). Randomized Controlled Trial of Internet-Delivered Cognitive Behavioral Therapy After Myocardial Infarction With Nonobstructive Coronary Arteries or Takotsubo Syndrome. Journal of the American Heart Association, 15(12), e047311. https://doi.org/10.1161/JAHA.125.047311
Lodder, P., Wicherts, J. M., Antens, M., Albus, C., Bessonov, I. S., Condén, E., Dulfer, K., Gostoli, S., Grande, G., Hedberg, P., Herrmann-Lingen, C., Jaarsma, T., Koo, M., Lin, P., Lin, T. K., Meyer, T., Pushkarev, G., Rafanelli, C., Raykh, O. I., … … Kupper, N. (2023). Type D Personality as a Risk Factor for Adverse Outcome in Patients With Cardiovascular Disease: An Individual Patient-Data Meta-analysis. Psychosomatic medicine, 85(2), 188–202. https://doi.org/10.1097/PSY.0000000000001164
Mahmud, S. H., Tosanovic, R., Deep, K., & ElAmm, C. (2026). Recurrent Takotsubo Cardiomyopathy Due to Benzodiazepine Withdrawal. JACC. Case reports, 31(2), 106119. https://doi.org/10.1016/j.jaccas.2025.106119
Malhotra, S., & Sahoo, S. (2017). Rebuilding the brain with psychotherapy. Indian journal of psychiatry, 59(4), 411–419. https://doi.org/10.4103/0019-5545.217299
Madaudo, C., Kurdi, H., Ielapi, J., Margineanu, C., Moscatelli, S., Bucciarelli-Ducci, C., Bromage, D., & Artico, J. (2026). The Role of Inflammation in Takotsubo Syndrome: From Pathogenic Pathways To Imaging Insights and Therapeutic Perspectives. Current cardiology reports, 28(1), 20. https://doi.org/10.1007/s11886-025-02342-4
Månsson, K. N., Salami, A., Frick, A., Carlbring, P., Andersson, G., Furmark, T., & Boraxbekk, C. J. (2016). Neuroplasticity in response to cognitive behavior therapy for social anxiety disorder. Translational psychiatry, 6(2), e727. https://doi.org/10.1038/tp.2015.218
Mogos, M. F., Ahn, S., Muchira, J. M., Osmundson, S., & Piano, M. R. (2023). Pregnancy-associated takotsubo cardiomyopathy hospitalizations in the United States. American journal of physiology. Heart and circulatory physiology, 325(3), H468–H474. https://doi.org/10.1152/ajpheart.00262.202
Muto, T., & Kyono, H. (2024). A woman with schizophrenia who died due to Takotsubo cardiomyopathy occurring after electroconvulsive therapy. BMC psychiatry, 24(1), 139. https://doi.org/10.1186/s12888-024-05593-7
Müller, H. H., Sperling, W., & Kornhuber, J. (2017). Cluster C Personality Accentuation in Patients with Takotsubo Cardiomyopathy Personality Traits Mark Vulnerability. Psychiatria Danubina, 29(1), 93.
Nayeri, A., Rafla-Yuan, E., Farber-Eger, E., Blair, M., Ziaeian, B., Cadeiras, M., McPherson, J. A., & Wells, Q. S. (2017). Pre-existing Psychiatric Illness is Associated With Increased Risk of Recurrent Takotsubo Cardiomyopathy. Psychosomatics, 58(5), 527–532. https://doi.org/10.1016/j.psym.2017.04.008
Nayeri, A., Rafla-Yuan, E., Krishnan, S., Ziaeian, B., Cadeiras, M., McPherson, J. A., & Wells, Q. S. (2018). Psychiatric Illness in Takotsubo (Stress) Cardiomyopathy: A Review. Psychosomatics, 59(3), 220–226. https://doi.org/10.1016/j.psym.2018.01.011
Novo, G., Arcari, L., Madaudo, C., Greco, A., Ragnatela, I., D'Alessandro, D., Di Lisi, D., Musumeci, B., Manguso, G., Cacciotti, L., Barbato, E., Galassi, A. R., Stiermaier, T., Eitel, I., Brunetti, N. D., Nunez Gil, I., & Santoro, F. (2025). Blood Cell Subtype patterns in Takotsubo Syndrome and acute coronary syndrome: analysis from the GEIST registry. Atherosclerosis, 411, 120571. https://doi.org/10.1016/j.atherosclerosis.2025.120571
Obrutu, O., Cui, Y., Maughan, J., Marano, P., Wei, J., Gulati, M., Lauzon, M., Herscovici, R., Shufelt, C., Rojas, N., Tjoe, B., Rutledge, T., & Bairey Merz, C. N. (2025). Psychosocial and clinical characteristics in Takotsubo syndrome. Biology of sex differences, 16(1), 42. https://doi.org/10.1186/s13293-025-00729-0
Oliveri, F., Goud, H. K., Mohammed, L., Mehkari, Z., Javed, M., Althwanay, A., Ahsan, F., & Rutkofsky, I. H. (2020). Role of Depression and Anxiety Disorders in Takotsubo Syndrome: The Psychiatric Side of Broken Heart. Cureus, 12(9), e10400. https://doi.org/10.7759/cureus.10400
Papadopoulos, S. F., Stavropoulou, E., Theodoropoulos, K. C., Kouparanis, A., Ziakas, A., Karamitsos, T., & Didagelos, M. (2024). Lithium Toxicity with Sinus Bradycardia and Takotsubo Syndrome in a Patient with Bipolar Disorder. Anatolian journal of cardiology, 28(12), E-35–36. https://doi.org/10.14744/AnatolJCardiol.2024.4749
Perry, K. W., & Fuller, R. W. (1997). Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats. Journal of neural transmission (Vienna, Austria : 1996), 104(8-9), 953–966. https://doi.org/10.1007/BF01285563
Prosperi, S., D'Amato, A., Labbro Francia, A., Monosilio, S., Cestiè, C., Marek Iannucci, S., Netti, L., Angotti, D., Filomena, D., Mariani, M. V., Myftari, V., Germanò, R., Cimino, S., Mancone, M., Badagliacca, R., Maestrini, V., Severino, P., & Vizza, C. D. (2024). Sodium-Glucose Cotransporter 2 Inhibitor Therapy in Different Scenarios of Heart Failure: An Overview of the Current Literature. International journal of molecular sciences, 25(21), 11458. https://doi.org/10.3390/ijms252111458
Radfar, A., Abohashem, S., Osborne, M. T., Wang, Y., Dar, T., Hassan, M. Z. O., Ghoneem, A., Naddaf, N., Patrich, T., Abbasi, T., Zureigat, H., Jaffer, J., Ghazi, P., Scott, J. A., Shin, L. M., Pitman, R. K., Neilan, T. G., Wood, M. J., & Tawakol, A. (2021). Stress-associated neurobiological activity associates with the risk for and timing of subsequent Takotsubo syndrome. European heart journal, 42(19), 1898–1908. https://doi.org/10.1093/eurheartj/ehab029
Rawish, E., Lemmer, F., Kurz, K., Mezger, M., Pätz, T., Stiermaier, T., & Eitel, I. (2026). SGLT2 inhibitors are associated with improved long-term survival in Takotsubo syndrome: insights from large-scale real-world data. European heart journal. Cardiovascular pharmacotherapy, 12(2), 75–84. https://doi.org/10.1093/ehjcvp/pvaf088
Roy, C. A., Soufi, G., & Greenway, K. T. (2024). Successful Electroconvulsive Therapy for Depression in a Patient With Recent History of Takotsubo Cardiomyopathy. The primary care companion for CNS disorders, 26(3), 23cr03671. https://doi.org/10.4088/PCC.23cr03671
Sabanci, R., Saaed, M., Bandi, A., Das, K., & Wilcox, M. (2024). Beyond the Benefits: A Case Study on the Complications of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors (Euglycemic Diabetic Ketoacidosis (DKA) and Takotsubo Cardiomyopathy). Cureus, 16(2), e55068. https://doi.org/10.7759/cureus.55068
Schnabel, R. B., Hasenfuß, G., Buchmann, S., Kahl, K. G., Aeschbacher, S., Osswald, S., & Angermann, C. E. (2021). Heart and brain interactions : Pathophysiology and management of cardio-psycho-neurological disorders. Wechselwirkungen zwischen Herz und Hirn : Pathophysiologie und Behandlung kardio-psycho-neurologischer Gesundheitsstörungen. Herz, 46(2), 138–149. https://doi.org/10.1007/s00059-021-05022-5
Selke, K. J., Dhar, G., & Cohn, J. M. (2011). Takotsubo cardiomyopathy associated with titration of duloxetine. Texas Heart Institute journal, 38(5), 573–576.
Sethi, Y., Murli, H., Kaiwan, O., Vora, V., Agarwal, P., Chopra, H., Padda, I., Kanithi, M., Popoviciu, M. S., & Cavalu, S. (2022). Broken Heart Syndrome: Evolving Molecular Mechanisms and Principles of Management. Journal of clinical medicine, 12(1), 125. https://doi.org/10.3390/jcm12010125
Shamaki, G. R., Anuforo, A., Safiriyu, I., Corteville, D., Sanghavi, M., Shah, S., & Clark, K. (2025). Serotonin Norepinephrine Reuptake Inhibitor Is Associated With Lower Mortality Among Patients Presenting With Takotsubo Cardiomyopathy. Journal of the American Heart Association, 14(13), e037951. https://doi.org/10.1161/JAHA.124.037951
Singh, T., Khan, H., Gamble, D. T., Scally, C., Newby, D. E., & Dawson, D. (2022). Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications. Circulation, 145(13), 1002–1019. https://doi.org/10.1161/CIRCULATIONAHA.121.055854
Sousa, D., Martins, F. A., Luís, Â., & Serralheiro, P. (2025). MicroRNAs in Takotsubo Syndrome: A Systematic Review of Regulatory Networks in Stress-Induced Cardiomyopathy. International journal of molecular sciences, 26(19), 9790. https://doi.org/10.3390/ijms26199790
Steiger, R., Tuovinen, N., Adukauskaite, A., Senoner, T., Spitaler, P., Bilgeri, V., Dabkowska-Mika, A., Siedentopf, C., Bauer, A., Gizewski, E. R., Hofer, A., Barbieri, F., & Dichtl, W. (2022). Limbic Responses to Aversive Visual Stimuli during the Acute and Recovery Phase of Takotsubo Syndrome. Journal of clinical medicine, 11(16), 4891. https://doi.org/10.3390/jcm11164891
Suárez Bagnasco, M., & Núñez-Gil, I. J. (2016). Psychological disorders in adults with inherited cardiomyopathies and Takotsubo syndrome. Trastornos psicológicos en adultos con miocardiopatías hereditarias y síndrome de Takotsubo. Medwave, 16(5), e6460. https://doi.org/10.5867/medwave.2016.05.6460
Suzuki, H., Matsumoto, Y., Kaneta, T., Sugimura, K., Takahashi, J., Fukumoto, Y., Takahashi, S., & Shimokawa, H. (2014). Evidence for brain activation in patients with takotsubo cardiomyopathy. Circulation journal : official journal of the Japanese Circulation Society, 78(1), 256–258. https://doi.org/10.1253/circj.cj-13-1276
Tan, B., Chen, L., Yan, S., Pan, H., Zhang, J., & Wei, H. (2024). Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis. Scientific reports, 14(1), 15167. https://doi.org/10.1038/s41598-024-66155-1
Tawakol, A., Ishai, A., Takx, R. A., Figueroa, A. L., Ali, A., Kaiser, Y., Truong, Q. A., Solomon, C. J., Calcagno, C., Mani, V., Tang, C. Y., Mulder, W. J., Murrough, J. W., Viceconte, N., Petrella, G., Pelliccia, F., Tanzilli, G., & Cicero, D. O. (2022). Unraveling Pathophysiology of Takotsubo Syndrome: The Emerging Role of the Oxidative Stress's Systemic Status. Journal of clinical medicine, 11(24), 7515. https://doi.org/10.3390/jcm11247515
Tunzi, M. A., Dinkha, L., Sharp, A. J., & Gore, R. S. (2020). Recurrent Takotsubo Cardiomyopathy: Getting to the Root of the Problem. The American journal of case reports, 21, e923067. https://doi.org/10.12659/AJCR.923067
Taylor, D. P., Eison, M. S., Riblet, L. A., & Vandermaelen, C. P. (1985). Pharmacological and clinical effects of buspirone. Pharmacology, biochemistry, and behavior, 23(4), 687–694. https://doi.org/10.1016/0091-3057(85)90438-1
Udemgba, C., Bravo-Jaimes, K., Mejia, M. O., Oli, P. R., Shrestha, D. B., Dawadi, S., Kadariya, D., & Velarde, G. (2024). Differences in clinical presentation and outcomes in pregnancy-associated Takotsubo Syndrome- A scoping review of the literature: Outcomes in pregnancy-associated Takotsubo. Current problems in cardiology, 49(1 Pt C), 102175. https://doi.org/10.1016/j.cpcardiol.2023.102175
Ullah, W., Cheema, M. A., Ashfaq, A., Mukhtar, M., Ali, Z., Ur Rashid, M., & Figueredo, V. (2020). A rare association of Takotsubo cardiomyopathy with neuroleptic malignant syndrome. Journal of community hospital internal medicine perspectives, 10(2), 133–137. https://doi.org/10.1080/20009666.2020.1742522
Vasconcelos, M. E., Mota, D., & Silva, T. (2024). Possible association between lithium intoxication and Takotsubo syndrome. BMJ case reports, 17(3), e257051. https://doi.org/10.1136/bcr-2023-257051
Vasudev, R., Rampal, U., Patel, H., Patel, K., Bikkina, M., & Shamoon, F. (2016). Selective Serotonin-norepinephrine Reuptake Inhibitors-induced Takotsubo Cardiomyopathy. North American journal of medical sciences, 8(7), 312–315. https://doi.org/10.4103/1947-2714.187153
Wang, T., Xiong, T., Yang, Y., Chen, X., Ma, Z., Zuo, B., Ning, D., Zhou, B., Song, R., Liu, X., & Wang, D. (2023). Estradiol-mediated small GTP-binding protein GDP dissociation stimulator induction contributes to sex differences in resilience to ferroptosis in takotsubo syndrome. Redox biology, 68, 102961. https://doi.org/10.1016/j.redox.2023.102961
Wittstein I. S. (2020). Why Age Matters in Takotsubo Syndrome. Journal of the American College of Cardiology, 75(16), 1878–1881. https://doi.org/10.1016/j.jacc.2020.03.030
Yang, G., Zhong, L., Wang, J., Yang, C., Cyganek, L., Hamdani, N., Zhou, X., Fan, X., El-Battrawy, I., & Akin, I. (2026). Roles of Catecholamines and Inflammation in Endothelial Dysfunction: a Study Using Takotsubo Syndrome Patient-specific hiPSC-ECs. Stem cell reviews and reports, 22(3), 1460–1476. https://doi.org/10.1007/s12015-026-11059-y
Zvonarev V. (2019). Takotsubo Cardiomyopathy: Medical and Psychiatric Aspects. Role of Psychotropic Medications in the Treatment of Adults with "Broken Heart" Syndrome. Cureus, 11(7), e5177. https://doi.org/10.7759/cureus.5177
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Karolina Figiel, Julia Gawlak, Zofia Tarnawska, Mateusz Gawin, Emilia Koziara, Mateusz Gadzina, Wojciech Sontag, Mateusz Zawisza, Aleksandra Golec, Maciej Krzesimir Kuświk
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
